Search This Blog

Monday, August 5, 2019

Foamix files U.S. application for FMX103 for acne-like skin condition

Foamix (FOMX -4.1%) has submitted a marketing application to the FDA seeking approval of topical foam FMX103 for the treatment of moderate-to-severe papulopustular rosacea (PR) in patients at least 18 years old.
PR is an inflammatory skin condition characterized by red pus-filled bumps that looks like acne. It occurs predominantly in fair-skinned people.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)